Comparison of local influenza vaccine effectiveness using two methods

被引:3
作者
Balasubramani, G. K. [1 ]
Zimmerman, Richard K. [2 ]
Eng, Heather [1 ]
Lyons, Jason [1 ]
Clarke, Lloyd [3 ]
Nowalk, Mary Patricia [2 ]
机构
[1] Univ Pittsburgh, Dept Epidemiol, Suite 600 Schenley Pl,4420 Bayard St, Pittsburgh, PA 15260 USA
[2] Univ Pittsburgh, Dept Family Med, Suite 520 Schenley Pl,4420 Bayard St, Pittsburgh, PA 15260 USA
[3] UPMC Hlth Syst Dept Pharm, Div Infect Dis, Pharm Dept, AMP 5th Floor Falk Med Bldg,3601 Fifth Ave, Pittsburgh, PA USA
基金
美国国家卫生研究院;
关键词
Influenza; Vaccine; Vaccine effectiveness; Administrative databases; UNITED-STATES; VIRUS; PROTECTION; CARE;
D O I
10.1016/j.vaccine.2021.01.013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: In some settings, research methods to determine influenza vaccine effectiveness (VE) may not be appropriate because of cost, time constraints, or other factors. Administrative database analysis of viral testing results and vaccination history may be a viable alternative. This study compared VE estimates from outpatient research and administrative databases. Methods: Using the test-negative, case-control design, data for 2017-2018 and 2018-2019 influenza seasons were collected using: 1) consent, specimen collection, RT-PCR testing and vaccine verification using multiple methods; and 2) an administrative database of outpatients with a clinical respiratory viral panel combined with electronic immunization records. Odds ratios for likelihood of influenza infection by vaccination status were calculated using multivariable logistic regression. VE = (1 - aOR) x 100. Results: Research participants were significantly younger (P < 0.001), more often white (69% vs. 59%; P < 0.001) than non-white and less frequently enrolled through the emergency department (35% vs. 72%; P < 0.001) than administrative database participants. VE was significant against all influenza and influenza A in each season and both seasons combined (37-49%). Point estimate differences between methods were evident, with higher VE in the research database, but insignificant due to low sample sizes. When enrollment sites were separately analyzed, there were significant differences in VE estimates for all influenza (66% research vs. 46% administrative P < 0.001) and influenza A (67% research vs. 49% administrative; P < 0.001) in the emergency department. Conclusions: The selection of the appropriate method for determining influenza vaccine effectiveness depends on many factors, including sample size, subgroups of interest, etc., suggesting that research estimates may be more generalizable. Other advantages of research databases for VE estimates include lack of clinician-related selection bias for testing and less misclassification of vaccination status. The advantages of the administrative databases are potentially shorter time to VE results and lower cost. (C) 2021 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1283 / 1289
页数:7
相关论文
共 18 条
  • [1] Does influenza vaccination status change physician ordering patterns for respiratory viral panels? Inspection for selection bias
    Balasubramani, G. K.
    Saul, Sean
    Nowalk, Mary Patricia
    Middleton, Donald B.
    Ferdinands, Jill M.
    Zimmerman, Richard K.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (01) : 91 - 96
  • [2] Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC) sentinel network: a cohort profile
    Correa, Ana
    Hinton, William
    McGovern, Andrew
    van Vlymen, Jeremy
    Yonova, Ivelina
    Jones, Simon
    de Lusignan, Simon
    [J]. BMJ OPEN, 2016, 6 (04):
  • [3] Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States
    Gaglani, Manjusha
    Pruszynski, Jessica
    Murthy, Kempapura
    Clipper, Lydia
    Robertson, Anne
    Reis, Michael
    Chung, Jessie R.
    Piedra, Pedro A.
    Avadhanula, Vasanthi
    Nowalk, Mary Patricia
    Zimmerman, Richard K.
    Jackson, Michael L.
    Jackson, Lisa A.
    Petrie, Joshua G.
    Ohmit, Suzanne E.
    Monto, Arnold S.
    McLean, Huong Q.
    Belongia, Edward A.
    Fry, Alicia M.
    Flannery, Brendan
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (10) : 1546 - 1556
  • [4] The abuse of power: The pervasive fallacy of power calculations for data analysis
    Hoenig, JM
    Heisey, DM
    [J]. AMERICAN STATISTICIAN, 2001, 55 (01) : 19 - 24
  • [5] Influenza Vaccine Effectiveness in the Elderly Based on Administrative Databases: Change in Immunization Habit as a Marker for Bias
    Hottes, Travis S.
    Skowronski, Danuta M.
    Hiebert, Brett
    Janjua, Naveed Z.
    Roos, Leslie L.
    Van Caeseele, Paul
    Law, Barbara J.
    De Serres, Gaston
    [J]. PLOS ONE, 2011, 6 (07):
  • [6] Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors
    Jackson, LA
    Nelson, JC
    Benson, P
    Neuzil, KM
    Reid, RJ
    Psaty, BM
    Heckbert, SR
    Larson, EB
    Weiss, NS
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2006, 35 (02) : 345 - 352
  • [7] Jackson ML, 2017, NEW ENGL J MED, V377, P534, DOI [10.1056/NEJMoa1700153, 10.1056/nejmoa1700153]
  • [8] Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort
    Kwong, Jeffrey C.
    Buchan, Sarah A.
    Chung, Hannah
    Campitelli, Michael A.
    Schwartz, Kevin L.
    Crowcroft, Natasha S.
    Jackson, Michael L.
    Karnauchow, Timothy
    Katz, Kevin
    McGeer, Allison J.
    McNally, J. Dayre
    Richardson, David C.
    Richardson, Susan E.
    Rosella, Laura C.
    Simor, Andrew
    Smieja, Marek
    Zahariadis, George
    Campigotto, Aaron
    Gubbay, Jonathan B.
    [J]. VACCINE, 2019, 37 (31) : 4392 - 4400
  • [9] Influenza Vaccine Effectiveness in the United States During 2012-2013: Variable Protection by Age and Virus Type
    McLean, Huong Q.
    Thompson, Mark G.
    Sundaram, Maria E.
    Kieke, Burney A.
    Gaglani, Manjusha
    Murthy, Kempapura
    Piedra, Pedro A.
    Zimmerman, Richard K.
    Nowalk, Mary Patricia
    Raviotta, Jonathan M.
    Jackson, Michael L.
    Jackson, Lisa
    Ohmit, Suzanne E.
    Petrie, Joshua G.
    Monto, Arnold S.
    Meece, Jennifer K.
    Thaker, Swathi N.
    Clippard, Jessie R.
    Spencer, Sarah M.
    Fry, Alicia M.
    Belongia, Edward A.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2015, 211 (10) : 1529 - 1540
  • [10] Estimating Vaccine Effectiveness Against Hospitalized Influenza During Pregnancy: Multicountry Protocol for a Retrospective Cohort Study
    Naleway, Allison L.
    Ball, Sarah
    Kwong, Jeffrey C.
    Wyant, Brandy E.
    Katz, Mark A.
    Regan, Annette K.
    Russell, Margaret L.
    Klein, Nicola P.
    Chung, Hannah
    Simmonds, Kimberley A.
    Azziz-Baumgartner, Eduardo
    Feldman, Becca S.
    Levy, Avram
    Fell, Deshayne B.
    Drews, Steven J.
    Garg, Shikha
    Effler, Paul
    Barda, Noam
    Irving, Stephanie A.
    Shifflett, Patricia
    Jackson, Michael L.
    Thompson, Mark G.
    [J]. JMIR RESEARCH PROTOCOLS, 2019, 8 (01):